Enzyme Corporation

ENZYME

Software as a service (SAAS) services featuring software for managing regulatory submissions and licenses; Software as a service (SAAS) services featuring software for managing and monitoring compliance with industry and governmental laws, regulations, and product registration rules for medical, medical device, medical diagnostic, biopharmaceutical, and biotechnology products; Software as a service (SAAS) services featuring software for auditing and risk management; Software as a service (SAAS) services featuring software for tracking and monitoring regulatory requirements in the fields of medical, medical device, medical diagnostic, biopharmaceutical, and biotechnology products for regulatory compliance purposes; Software as a service (SAAS) services featuring software for aiding in the design of medical device, medical diagnostic, biopharmaceutical, and biotechnology products;

ENZYME

Software as a service services for use by businesses and organizations in the health care industry to perform a variety of functions, namely, risk management, quality assurance and control, records generation and management, document control, data management, regulatory compliance, industry standards compliance, regulatory submissions, training, asset management, human capital management, workforce acquisition and optimization, staffing, employee recruitment and hiring; software as a service services for use by businesses and organizations in the health care industry to design, implement, and optimize business processes, namely, quality control, risk management, regulatory compliance, records management, asset management, procurement, staffing, training, and employee recruitment and hiring;